What does uplizna — intangible assets, net (excluding goodwill) mean?

The net book value of acquired intellectual property and product rights specifically tied to the UPLIZNA therapeutic.

UPLIZNA — Intangible Assets, Net (Excluding Goodwill)

Products & Services · Intangible Assets, Net (Excluding Goodwill)

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ2 2025

Last reportedQ2 2025

How to read this metric

An increase typically reflects recent acquisitions or capital investments in product rights, while a decrease indicates ongoing amortization or potential impairment charges.

Detailed definition

This metric represents the carrying value of identifiable intangible assets associated with the UPLIZNA product line, ne...

Peer comparison

Comparable to 'Product Rights' or 'Acquired Intangible Assets' reported by other biopharmaceutical firms for specific drug portfolios.

Metric ID: amgn_segment_uplizna_intangible_assets_net_excluding_goodwill

Historical Data

1 periods

	Q2 '25
Value	$350.00M

Similar Metrics at Other Companies

AbbVieABBV View metric

Merck & Co.MRK View metric

AbbVieABBV View metric

Morgan StanleyMS View metric

UnitedHealth GroupUNH View metric

Frequently Asked Questions

What is Amgen's uplizna — intangible assets, net (excluding goodwill)?: Amgen (AMGN) reported uplizna — intangible assets, net (excluding goodwill) of $350.00M in Q2 2025.
What does uplizna — intangible assets, net (excluding goodwill) mean?: The net book value of acquired intellectual property and product rights specifically tied to the UPLIZNA therapeutic.